Alchem International is an API manufacturer based in India. It holds 7 active US drug master files across a filed portfolio of 6 molecules. Its GMP standing is certified by US FDA, CDSCO (India) and NAFDAC (NG). Its most recent recorded inspection, by US FDA, closed on 4 July 2025 as VAI. Customs aggregates show $44.8M of exports covering 497 molecules to 51 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Alwar, India | 3009344588 |
| Faridabad, India | 3003310718 |
| Village, India | Not on file |
| district faridabad 121004, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Scopolamine | US FDA | 2 |
| Atropine | US FDA | 1 |
| Colchicine | US FDA | 1 |
| Digoxin | US FDA | 1 |
| Methscopolamine Bromide | US FDA | 1 |
| Nicotine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 2 |
| CDSCO (India) | None | 2 |
| NAFDAC (NG) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $6.6M | 29 |
| 2025 | Not reported | $44.8M | 51 |
| 2024 | Not reported | $29.0M | 45 |
| 2023 | Not reported | $26.5M | 42 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Alchem International comes back tiered against every other supplier able to file there.
Start for free